Annual Current Liabilities
$167.69 M
+$28.67 M+20.62%
December 31, 2023
Summary
- As of February 8, 2025, FOLD annual total current liabilities is $167.69 million, with the most recent change of +$28.67 million (+20.62%) on December 31, 2023.
- During the last 3 years, FOLD annual current liabilities has risen by +$38.01 million (+29.31%).
- FOLD annual current liabilities is now at all-time high.
Performance
FOLD Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$158.14 M
-$9.93 M-5.91%
September 30, 2024
Summary
- As of February 8, 2025, FOLD quarterly total current liabilities is $158.14 million, with the most recent change of -$9.93 million (-5.91%) on September 30, 2024.
- Over the past year, FOLD quarterly current liabilities has dropped by -$11.32 million (-6.68%).
- FOLD quarterly current liabilities is now -6.68% below its all-time high of $169.45 million, reached on September 30, 2023.
Performance
FOLD Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
FOLD Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +20.6% | -6.7% |
3 y3 years | +29.3% | -6.7% |
5 y5 years | +94.7% | -6.7% |
FOLD Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +20.6% | -6.7% | +21.9% |
5 y | 5-year | at high | +30.2% | -6.7% | +72.4% |
alltime | all time | at high | +6368.2% | -6.7% | +5999.8% |
Amicus Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $158.14 M(-5.9%) |
Jun 2024 | - | $168.07 M(+18.3%) |
Mar 2024 | - | $142.10 M(-15.3%) |
Dec 2023 | $167.69 M(+20.6%) | $167.69 M(-1.0%) |
Sep 2023 | - | $169.45 M(+6.4%) |
Jun 2023 | - | $159.24 M(+15.1%) |
Mar 2023 | - | $138.38 M(-0.5%) |
Dec 2022 | $139.02 M(-4.8%) | $139.02 M(-15.6%) |
Sep 2022 | - | $164.65 M(+0.0%) |
Jun 2022 | - | $164.63 M(+26.9%) |
Mar 2022 | - | $129.70 M(-11.1%) |
Dec 2021 | $145.97 M(+12.6%) | $145.97 M(+20.5%) |
Sep 2021 | - | $121.10 M(+8.1%) |
Jun 2021 | - | $111.99 M(+12.4%) |
Mar 2021 | - | $99.65 M(-23.2%) |
Dec 2020 | $129.68 M(+0.7%) | $129.68 M(+16.1%) |
Sep 2020 | - | $111.73 M(+3.2%) |
Jun 2020 | - | $108.30 M(+18.1%) |
Mar 2020 | - | $91.71 M(-28.8%) |
Dec 2019 | $128.81 M(+49.6%) | $128.81 M(+38.4%) |
Sep 2019 | - | $93.08 M(+3.9%) |
Jun 2019 | - | $89.55 M(+35.9%) |
Mar 2019 | - | $65.87 M(-23.5%) |
Dec 2018 | $86.13 M(+23.0%) | $86.13 M(+30.7%) |
Sep 2018 | - | $65.88 M(+24.4%) |
Jun 2018 | - | $52.96 M(-62.4%) |
Mar 2018 | - | $140.71 M(+100.9%) |
Dec 2017 | $70.04 M(-36.9%) | $70.04 M(+2.8%) |
Sep 2017 | - | $68.16 M(-32.3%) |
Jun 2017 | - | $100.68 M(-8.1%) |
Mar 2017 | - | $109.60 M(-1.2%) |
Dec 2016 | $110.96 M(+50.7%) | $110.96 M(+29.6%) |
Sep 2016 | - | $85.61 M(+6.4%) |
Jun 2016 | - | $80.46 M(+24.9%) |
Mar 2016 | - | $64.43 M(-12.5%) |
Dec 2015 | $73.62 M | $73.62 M(+105.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2015 | - | $35.87 M(+112.2%) |
Jun 2015 | - | $16.90 M(-19.6%) |
Mar 2015 | - | $21.02 M(+4.1%) |
Dec 2014 | $20.18 M(+93.0%) | $20.18 M(+46.0%) |
Sep 2014 | - | $13.82 M(+23.7%) |
Jun 2014 | - | $11.17 M(+19.3%) |
Mar 2014 | - | $9.37 M(-10.5%) |
Dec 2013 | $10.46 M(+13.2%) | $10.46 M(+21.7%) |
Sep 2013 | - | $8.60 M(-13.7%) |
Jun 2013 | - | $9.97 M(+24.7%) |
Mar 2013 | - | $8.00 M(-13.5%) |
Dec 2012 | $9.24 M(-52.0%) | $9.24 M(-6.9%) |
Sep 2012 | - | $9.93 M(-44.3%) |
Jun 2012 | - | $17.81 M(+0.3%) |
Mar 2012 | - | $17.77 M(-7.7%) |
Dec 2011 | $19.26 M(+18.7%) | $19.26 M(+3.4%) |
Sep 2011 | - | $18.63 M(+10.4%) |
Jun 2011 | - | $16.88 M(+1.5%) |
Mar 2011 | - | $16.64 M(+2.5%) |
Dec 2010 | $16.22 M(+44.9%) | $16.22 M(+99.1%) |
Sep 2010 | - | $8.15 M(+14.0%) |
Jun 2010 | - | $7.15 M(-19.1%) |
Mar 2010 | - | $8.84 M(-21.0%) |
Dec 2009 | $11.19 M(-16.3%) | $11.19 M(-34.5%) |
Sep 2009 | - | $17.08 M(+12.1%) |
Jun 2009 | - | $15.24 M(+21.4%) |
Mar 2009 | - | $12.55 M(-6.2%) |
Dec 2008 | $13.38 M(-15.3%) | $13.38 M(-10.4%) |
Sep 2008 | - | $14.94 M(-2.4%) |
Jun 2008 | - | $15.30 M(+3.3%) |
Mar 2008 | - | $14.81 M(-6.2%) |
Dec 2007 | $15.79 M(+54.7%) | $15.79 M(+65.0%) |
Sep 2007 | - | $9.57 M(+37.4%) |
Jun 2007 | - | $6.96 M(-18.7%) |
Mar 2007 | - | $8.57 M(-16.1%) |
Dec 2006 | $10.21 M(+293.7%) | $10.21 M(+293.7%) |
Dec 2005 | $2.59 M | $2.59 M |
FAQ
- What is Amicus Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics annual current liabilities year-on-year change?
- What is Amicus Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly current liabilities year-on-year change?
What is Amicus Therapeutics annual total current liabilities?
The current annual current liabilities of FOLD is $167.69 M
What is the all time high annual current liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total current liabilities is $167.69 M
What is Amicus Therapeutics annual current liabilities year-on-year change?
Over the past year, FOLD annual total current liabilities has changed by +$28.67 M (+20.62%)
What is Amicus Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of FOLD is $158.14 M
What is the all time high quarterly current liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total current liabilities is $169.45 M
What is Amicus Therapeutics quarterly current liabilities year-on-year change?
Over the past year, FOLD quarterly total current liabilities has changed by -$11.32 M (-6.68%)